Cargando…
Ranolazine for Prevention of Atrial Fibrillation after Cardiac Surgery: A Systematic Review
Postoperative atrial fibrillation (POAF) remains a major risk after cardiac surgery and is associated with an increased risk of stroke, length of stay, mortality, and cost. Ranolazine, an anti-anginal drug, also has anti-arrhythmic properties. The present study is to evaluate the effectiveness of ra...
Autores principales: | Patel, Nirav, Kluger, Jeffery |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037341/ https://www.ncbi.nlm.nih.gov/pubmed/30009098 http://dx.doi.org/10.7759/cureus.2584 |
Ejemplares similares
-
Ranolazine Toxicity Secondary to Paxlovid
por: Casey, Bradley, et al.
Publicado: (2023) -
Efficacy of ranolazine in preventing atrial fibrillation following cardiac surgery: Results from a meta-analysis
por: Trivedi, Chintan, et al.
Publicado: (2017) -
Atrial fibrillation and psychological factors: a systematic review
por: Galli, Federica, et al.
Publicado: (2017) -
Refractory atrial fibrillation effectively treated with ranolazine
por: Vaishnav, Aditi, et al.
Publicado: (2014) -
Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis
por: Yuan, Chengdai, et al.
Publicado: (2021)